Kazatomprom's Acid Test: Cost Squeeze Meets Strategic Stockpiling
As global nuclear demand surges, Kazatomprom battles surging sulfuric acid costs and a stronger tenge while building inventories and weighing a major new Chinese contract.
KAP.IL · Earnings Call · 2026-08-21
The Cost Reality
Kazatomprom’s first-half 2026 results paint a picture of a company caught between a booming uranium market and sharply rising costs. While group-level sales held steady at over 7,500 tons and the average realized price jumped 16% year-on-year to $67.88 per pound, the sulfuric acid price surge and the appreciation of the Kazakh tenge are eating into profitability. CFO Marat Tulebayev, when asked to bridge the $2 per pound increase in C1 cash cost guidance, admitted the two factors were roughly equal in impact: “the effect from these two factors are pretty much equal” — Marat Tulebayev, Chief Financial Officer · 2026-08-21. The company now expects C1 cash costs to rise 37% in US dollar terms for the half, and all-in sustaining costs are up 25%. The market backdrop is undeniably supportive. CEO Meirzhan Yussupov noted that the U.S. Department of Energy has committed a record $17.5 billion in federal funding, and over 70 reactors are under construction globally. Nuclear energy has "officially transitioned from a policy debate on paper into operational execution." Yet Kazatomprom is not immune to industry-wide inflation. The company’s own spot price for sulfuric acid raw material (sulfur) has quadrupled over the past year, though the local sulfuric acid price increase has been more muted. Management emphasizes that diversified supply channels from domestic smelters and cross-border producers provide a buffer, but the cost trajectory remains a key investor concern.Inventory as a Strategic Weapon
One of the most striking moves in the quarter was the build-up of inventories. Consolidated group inventory now exceeds 8,200 tons, a 23% year-on-year increase, while company-level inventory rose 15% to 6,200 tons. This is not a sign of weak demand but a deliberate comfortable level of stockpiling, as utilities worldwide shift from just-in-time to just-in-case procurement. The CEO framed it explicitly: “We will not sell our pounds underpriced.” — Meirzhan Yussupov, CEO or Managing Director (inferred as leading the company presentation) · 2026-08-21 The inventory provides flexibility to optimize sales timing and capture higher prices. Managing Director Aldiyar Karpay explained, "The inventory levels may vary from year to year, depending on the production level and the sales volume," but the company remains committed to meeting its 2026 sales guidance. This strategic stockpile also aligns with the broader nuclear fuel cycle: with lead times of roughly two years from mine to reactor, utilities must hold inventories as insurance. Kazatomprom’s build-up positions it to benefit from any further price increases, while also signaling that it is not desperate to offload volume in a weak market.A New Chapter in China
Perhaps the most significant disclosure on the call was the announcement of new transactions requiring an extraordinary general meeting (EGM) approval. Karpay clarified that these are "new transactions that we announced today for the EGM, and it's not related to the previously announced transaction" — a direct reference to a contract with a Chinese counterparty that exceeds a quarter of the company’s standalone book value. This is a material event, as it signals deepening ties with China’s rapidly expanding nuclear program. When asked about the size, Karpay corrected that it is more than a quarter, not half, but the financial weight is still substantial. The company declined to disclose terms, citing confidentiality. The timing is notable. China recently approved four new nuclear projects (eight reactors), and India is pushing to commission five new reactors this decade. Kazatomprom, as the world’s largest uranium producer (39% of primary supply), is a natural partner for these expansion plans. This new contract could secure long-term demand for its substantial inventory and production growth.Beyond the Numbers
The company also confirmed its production and sales volume guidance for 2026, but revised down its revenue outlook solely due to the strengthening tenge — a non-operational hit. Meanwhile, capital expenditure guidance was raised, partly because sulfuric acid costs capitalised on initial ore preparation, but also as a proactive investment in future growth: “We are deploying capital now to secure long-term growth ahead of the demand.” — Meirzhan Yussupov, CEO or Managing Director (inferred as leading the company presentation) · 2026-08-21 Strategically, Kazatomprom is exploring opportunities to move downstream into conversion and enrichment. Chief Strategy Officer Dastan Kosherbayev noted they are "entertaining our options" and have several offers on the table, but no public update yet. This could be a major value driver, capturing more of the fuel cycle. The call also touched on the impact of the Middle East crisis, but management stressed that transportation routes via the Trans-Caspian corridor have been reliable, and selling expense increases were due to delivery mix changes, not conflict. In sum, Kazatomprom is navigating a period of rising costs and currency headwinds, but it is doing so from a position of strength: record demand, a strategic inventory buffer, and a potential new Chinese contract that could underpin decades of sales. The cost inflation is real, but the company’s ability to pass through prices — evidenced by the 16% realized price increase — suggests it can maintain profitability. The real test will be whether the tenge stabilizes and whether the EGM approves the Chinese deal, which could be a game-changer for the company’s revenue visibility.We will not sell our pounds underpriced.